Evertt Laboratories Acquires Quinnova Pharmaceuticals

Article

Everett Laboratories acquires Quinnova Pharmaceuticals, a specialty pharmaceutical company.

Everett Laboratories, a privately held specialty pharmaceutical company and a subsidiary of Exeltis, headquarted in Madrid, Spain, has acquired Quinnova Pharmaceuticals, from parent company Amneal Enterprises.

The acquisition will result in the strategic expansion of Everett into the US dermatology market.

Summary: Everett Laboratories

Recent Videos
Behind the Headlines episode 6
CPHI Milan 2024: Highlighting the Benefits of Integrated Services
Behind the Headlines episode 5
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content